LungBlog

All About Malignant Mesothelioma, an online resource for information about mesothelioma causes, symptoms and treatments, has recently published a revised section on mesothelioma drug treatments.

Statins reverse doxorubicin resistance in human malignant mesothelioma cells in culture, a finding that may lead to new clinical strategies to improve doxorubicin efficacy in this hard to treat cancer.

Malignant mesothelioma — cancer of the lining of the chest or abdomen — is associated with exposure to asbestos and tends to be rare.  This is a truly fascinating article that suggests that some may have a genetic predisposition to the disease so that its cause is not solely due to exposure to environmental factors.

Scientists believe that pemetrexed should be the standard treatment choice for unresectable malignant pleural mesothelioma (MPM) and recurrent metastatic non-small cell lung cancer (NSCLC).

In June 2005, a Californian study published in the American Journal of Respiratory and Critical Care Medicine concluded there was an increased risk of mesothelioma from living near naturally occurring asbestos.

According to the research findings published in National Academy of Sciences Journal, the anti-cancer drug Onconase might be one of the most effective methods of treatment for mesothelioma and lung cancer caused by asbestos.

A drug for the asbestos-linked cancer mesothelioma has been blocked for widespread use by the NHS in England and Wales.